Equity Profile

PBH

Prestige Consumer Healthcare Inc.

Health CarePharmaceuticals$2.2B

Aug6Thu

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceutical products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance compared to analysts' expectations.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to increase sales and market share in a competitive environment.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceutical products. With a market cap of $2 billion, the company plays a significant role in consumer health, particularly as demand for health-related products continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In Q4-2026, Prestige reported an EPS of $1.23, missing estimates by 11.7%. The stock reacted positively, gaining 2.78% the following day despite the miss.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as analysts await the upcoming earnings report. Investors are particularly focused on whether the company can recover from recent EPS misses.

Bull Case

If Prestige can demonstrate strong revenue growth and improved margins, it may signal a turnaround, boosting investor confidence.

Bear Case

Conversely, continued misses on EPS and revenue could indicate deeper issues within the company, leading to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed $1.23, indicating a recovery from previous misses?

A positive EPS result could restore investor confidence and support a bullish outlook.

What is the revenue growth rate compared to last year?

Revenue growth is vital for assessing the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a rebound in consumer health demand, which could drive better-than-expected results this quarter.

Supporting Evidence

Options are pricing a 12.18% move, indicating significant uncertainty that may not reflect the company's underlying strength.

The recent positive stock reaction despite EPS misses suggests that investors may be willing to overlook short-term setbacks.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate centers around whether Prestige can overcome recent performance issues and regain growth momentum.

Bull Confirmed If

An EPS of $1.30 or higher would confirm the bull case, indicating effective cost management and sales growth.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case, suggesting ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting heightened uncertainty around the earnings report.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.7%, with a raw directional average of -1.5% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around 5.17%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movements as investors await further clarity from management.

Miss

Should the company miss again, history indicates a likely decline of around 3.16%, raising concerns about its operational health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the OTC segment.
2Management's commentary on cost control measures and their impact on margins.
3Insights into consumer demand trends for health products.
4Any guidance on future earnings expectations or market conditions.
5Responses to analyst questions regarding competitive pressures in the market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceutical products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance compared to analysts' expectations.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to increase sales and market share in a competitive environment.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In Q4-2026, Prestige reported an EPS of $1.23, missing estimates by 11.7%. The stock reacted positively, gaining 2.78% the following day despite the miss.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as analysts await the upcoming earnings report. Investors are particularly focused on whether the company can recover from recent EPS misses.

Bull Case

If Prestige can demonstrate strong revenue growth and improved margins, it may signal a turnaround, boosting investor confidence.

Bear Case

Conversely, continued misses on EPS and revenue could indicate deeper issues within the company, leading to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed $1.23, indicating a recovery from previous misses?

A positive EPS result could restore investor confidence and support a bullish outlook.

What is the revenue growth rate compared to last year?

Revenue growth is vital for assessing the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a rebound in consumer health demand, which could drive better-than-expected results this quarter.

Supporting Evidence

Options are pricing a 12.18% move, indicating significant uncertainty that may not reflect the company's underlying strength.

The recent positive stock reaction despite EPS misses suggests that investors may be willing to overlook short-term setbacks.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate centers around whether Prestige can overcome recent performance issues and regain growth momentum.

Bull Confirmed If

An EPS of $1.30 or higher would confirm the bull case, indicating effective cost management and sales growth.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case, suggesting ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting heightened uncertainty around the earnings report.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around 5.17%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movements as investors await further clarity from management.

Miss

Should the company miss again, history indicates a likely decline of around 3.16%, raising concerns about its operational health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the OTC segment.
2Management's commentary on cost control measures and their impact on margins.
3Insights into consumer demand trends for health products.
4Any guidance on future earnings expectations or market conditions.
5Responses to analyst questions regarding competitive pressures in the market.